Supports small, mid-size and large pharma companies to bridge gaps in their expertise and/or resources during clinical development and post-marketing.
Capitalizes on extensive experience in all clinical stages of drug development
Serves as external resource for companies in preparation of clinical trial protocols, amendment preparation, IB compilation etc
Helps clinical projects to increase value and limit risk by making design and decision making easier, better and more creative
Michael Wrangstadh PhD
Michael is a versatile and accomplished scientific officer offering over 20 years’ experience in drug development, disease area strategy development, drug portfolio development, project leadership, process improvement and change management within the international life science industry.
He is qualified with a PhD in Marine Microbiology and a post-Doctorate in Research Microbiology with strong skills in providing scientific and operational leadership while identifying, evaluating and capitalizing on innovative product development opportunities.
Michael has a proven record of establishing company’s strategic R&D roadmap within selected projects and providing scientific input into company’s R&D programmes.
He has hands-on experience in working with recognized research centers in both early and late stages of product lifecycle and specializes in their application to multiple therapy areas including those of neuroscience, transplant, gastrointestinal, cardiovascular, respiratory, infectious and autoimmune diseases.
For additional information, please see the full profile of Michael Wrangstadh on Linkedin